Literature DB >> 15838019

Characterization of a cluster of three glycosyltransferase enzymes essential for Moraxella catarrhalis lipooligosaccharide assembly.

Katie J Edwards1, Simon Allen, Bradford W Gibson, Anthony A Campagnari.   

Abstract

Moraxella catarrhalis isolates express lipooligosaccharide (LOS) molecules on their surface, which share epitopes similar to that of the Neisseria and Haemophilus species. These common LOS epitopes have been implicated in various steps of pathogenesis for the different organisms. In this study, a cluster of three LOS glycosyltransferase genes (lgt) were identified in M. catarrhalis 7169, a strain that produces a serotype B LOS. Mutants in these glycosyltransferase genes were constructed, and the resulting LOS phenotypes were consistent with varying degrees of truncation compared to wild-type LOS. The LOS structures of each lgt mutant were no longer detected by a monoclonal antibody (MAb 4G5) specific to a highly conserved terminal epitope nor by a monoclonal antibody (MAb 3F7) specific to the serotype B LOS side chain. Mass spectrometry of the LOS glycoforms assembled by two of these lgt mutants indicated that lgt1 encodes an alpha(1-2) glucosyltransferase and the lgt2 encodes a beta(1-4) galactosyltransferase. However, these structural studies could not delineate the function for lgt3. Therefore, M. catarrhalis lgt3 was introduced into a defined beta(1-4) glucosyltransferase Haemophilus ducreyi 35000glu- mutant in trans, and monoclonal antibody analysis confirmed that Lgt3 complemented the LOS defect. These data suggest that lgt3 encodes a glucosyltransferase involved in the addition of a beta(1-4)-linked glucose to the inner core. Furthermore, we conclude that this enzymatic step is essential for the assembly of the complete LOS glycoform expressed by M. catarrhalis 7169.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15838019      PMCID: PMC1082826          DOI: 10.1128/JB.187.9.2939-2947.2005

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  59 in total

1.  Construction and characterization of Moraxella catarrhalis mutants defective in expression of transferrin receptors.

Authors:  N R Luke; A A Campagnari
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

2.  Increased substitution of phosphate groups in lipopolysaccharides and lipid A of polymyxin-resistant mutants of Salmonella typhimurium and Escherichia coli.

Authors:  I M Helander; K Nummila; I Kilpeläinen; M Vaara
Journal:  Prog Clin Biol Res       Date:  1995

Review 3.  Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response.

Authors:  T F Murphy
Journal:  Microbiol Rev       Date:  1996-06

4.  Lack of serotype-specific antibody response to lipopolysaccharide antigens of Moraxella catarrhalis during lower respiratory tract infection.

Authors:  M Rahman; T Holme; I Jönsson; A Krook
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-04       Impact factor: 3.267

5.  An analysis of the complete nucleotide sequence of the Haemophilus ducreyi broad-host-range plasmid pLS88.

Authors:  L G Dixon; W L Albritton; P J Willson
Journal:  Plasmid       Date:  1994-09       Impact factor: 3.466

6.  The influence of capsulation and lipooligosaccharide structure on neutrophil adhesion molecule expression and endothelial injury by Neisseria meningitidis.

Authors:  N J Klein; C A Ison; M Peakman; M Levin; S Hammerschmidt; M Frosch; R S Heyderman
Journal:  J Infect Dis       Date:  1996-01       Impact factor: 5.226

7.  Matrix-assisted laser desorption/ionization mass spectrometry: improved matrix for oligosaccharides.

Authors:  M D Mohr; K O Börnsen; H M Widmer
Journal:  Rapid Commun Mass Spectrom       Date:  1995       Impact factor: 2.419

8.  Structural studies of the O-antigen oligosaccharides from two strains of Moraxella catarrhalis serotype C.

Authors:  P Edebrink; P E Jansson; M M Rahman; G Widmalm; T Holme; M Rahman
Journal:  Carbohydr Res       Date:  1995-01-17       Impact factor: 2.104

9.  Inner core biosynthesis of lipooligosaccharide (LOS) in Neisseria meningitidis serogroup B: identification and role in LOS assembly of the alpha1,2 N-acetylglucosamine transferase (RfaK).

Authors:  C M Kahler; R W Carlson; M M Rahman; L E Martin; D S Stephens
Journal:  J Bacteriol       Date:  1996-03       Impact factor: 3.490

10.  Antibody response in rabbits to serotype-specific determinants in lipopolysaccharides from Moraxella catarrhalis.

Authors:  M Rahman; T Holme
Journal:  J Med Microbiol       Date:  1996-05       Impact factor: 2.472

View more
  14 in total

1.  Multiplex PCR assay that identifies the major lipooligosaccharide serotype expressed by Moraxella catarrhalis clinical isolates.

Authors:  Katie J Edwards; Johanna M Schwingel; Anup K Datta; Anthony A Campagnari
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

2.  Comparative proteomic analysis of the Haemophilus ducreyi porin-deficient mutant 35000HP::P2AB.

Authors:  Jeremiah J Davie; Anthony A Campagnari
Journal:  J Bacteriol       Date:  2008-12-19       Impact factor: 3.490

3.  Identification of two late acyltransferase genes responsible for lipid A biosynthesis in Moraxella catarrhalis.

Authors:  Song Gao; Daxin Peng; Wenhong Zhang; Artur Muszyński; Russell W Carlson; Xin-Xing Gu
Journal:  FEBS J       Date:  2008-09-13       Impact factor: 5.542

4.  Characterization of the six glycosyltransferases involved in the biosynthesis of Yersinia enterocolitica serotype O:3 lipopolysaccharide outer core.

Authors:  Elise Pinta; Katarzyna Anna Duda; Anna Hanuszkiewicz; Tiina A Salminen; José Antonio Bengoechea; Heidi Hyytiäinen; Buko Lindner; Joanna Radziejewska-Lebrecht; Otto Holst; Mikael Skurnik
Journal:  J Biol Chem       Date:  2010-07-01       Impact factor: 5.157

5.  The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization.

Authors:  Thomas A Russo; Janet M Beanan; Ruth Olson; Ulrike MacDonald; Andrew D Cox; Frank St Michael; Evgeny V Vinogradov; Brad Spellberg; Nicole R Luke-Marshall; Anthony A Campagnari
Journal:  Infect Immun       Date:  2013-01-07       Impact factor: 3.441

Review 6.  Panel 4: Report of the Microbiology Panel.

Authors:  Stephen J Barenkamp; Tasnee Chonmaitree; Anders P Hakansson; Terho Heikkinen; Samantha King; Johanna Nokso-Koivisto; Laura A Novotny; Janak A Patel; Melinda Pettigrew; W Edward Swords
Journal:  Otolaryngol Head Neck Surg       Date:  2017-04       Impact factor: 3.497

7.  Moraxella catarrhalis bacterium without endotoxin, a potential vaccine candidate.

Authors:  Daxin Peng; Wenzhou Hong; Biswa P Choudhury; Russell W Carlson; Xin-Xing Gu
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

8.  Use of Moraxella catarrhalis lipooligosaccharide mutants to identify specific oligosaccharide epitopes recognized by human serum antibodies.

Authors:  Johanna M Schwingel; Katie J Edwards; Andrew D Cox; Hussein Masoud; James C Richards; Frank St Michael; Carmen D Tekwe; Sanjay Sethi; Timothy F Murphy; Anthony A Campagnari
Journal:  Infect Immun       Date:  2009-08-03       Impact factor: 3.441

9.  Characterization of a trifunctional glucosyltransferase essential for Moraxella catarrhalis lipooligosaccharide assembly.

Authors:  Nicole R Luke-Marshall; Katie J Edwards; Shauna Sauberan; Frank St Michael; Evgeny V Vinogradov; Andrew D Cox; Anthony A Campagnari
Journal:  Glycobiology       Date:  2013-05-29       Impact factor: 4.313

10.  Galactose residues on the lipooligosaccharide of Moraxella catarrhalis 26404 form the epitope recognized by the bactericidal antiserum from conjugate vaccination.

Authors:  Shengqing Yu; Hang Xie; Anup Datta; Natasha Naidu; Xin-Xing Gu
Journal:  Infect Immun       Date:  2008-06-16       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.